Phytotherapeutics oridonin and ponicidin show additive effects combined with irradiation in pancreatic cancer in vitro

Liermann, Jakob; Naumann, Patrick; Fortunato, Franco; Schmid, Thomas E.; Weber, Klaus-Josef; Debus, Jürgen; Combs, Stephanie E.

doi:10.1515/raon-2017-0048

Abstract

Background

Chemoradiation of locally advanced non-metastatic pancreatic cancer can lead to secondary operability by tumor mass reduction. Here, we analyzed radiomodulating effects of oridonin and ponicidin in pancreatic cancer in vitro. Both agents are ent-kaurane diterpenoids, extracted from Isodon rubescens, a plant that is well known in Traditional Chinese Medicine. Cytotoxic effects have recently been shown in different tumor entities for both agents.

Materials and methods

Pancreatic cancer cell lines AsPC-1, BxPC-3, Panc-1 and MIA PaCa-2 were pretreated with oridonin or ponicidin and irradiated with 2 Gy to 6 Gy. Long-term survival was determined by clonogenic assay. Cell cycle effects and intensity of γH2AX as indicator for DNA double-strand breaks were investigated by flow cytometry. Western blotting was used to study the DNA double-strand break repair proteins Ku70, Ku80 and XRCC4.

Results

Oridonin and ponicidin lead to a dose-dependent reduction of clonogenic survival and an increase in γH2AX. Combined with irradiation we observed additive effects and a prolonged G2/M-arrest. No relevant changes in the levels of the DNA double-strand break repair proteins were detected.

Conclusions

Pretreatment with oridonin or ponicidin followed by irradiation lead to an additional reduction in survival of pancreatic cancer cells in vitro, presumably explained by an induced prolonged G2/M-arrest. Both agents seem to induce DNA double-strand breaks but do not interact with the non-homologous end joining (NHEJ) pathway.

References

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29. 10.3322/caac.2125425559415
Open DOI Search in Google Scholar Back to article
Kleeff J, Friess H, Buchler MW. Neoadjuvant therapy for pancreatic cancer. Br J Surg 2007; 94: 261-2. 10.1002/bjs.573717315287
Open DOI Search in Google Scholar Back to article
Gillen S, Schuster T, Meyer Zum Buschenfelde C, Friess H, Kleeff J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 2010; 7: e1000267. 10.1371/journal.pmed.100026720422030
Open DOI Search in Google Scholar Back to article
Naumann P, Habermehl D, Welzel T, Debus J, Combs SE. Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer. Strahlenther Onkol 2013; 189: 745-52. 10.1007/s00066-013-0393-323896631
Open DOI Search in Google Scholar Back to article
Han QB, Li ML, Li SH, Mou YK, Lin ZW, Sun HD. Ent-kaurane diterpenoids from Isodon rubescens var. lushanensis. Chem Pharm Bull (Tokyo) 2003; 51: 790-3.1284358310.1248/cpb.51.790
Open DOI Search in Google Scholar Back to article
Owona BA, Schluesener HJ. Molecular insight in the multifunctional effects of oridonin. Drugs R D 2015; 15: 233-44. 10.1007/s40268-015-0102-z26290464
Open DOI Search in Google Scholar Back to article
Tian W, Chen SY. Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin. Chin J Integr Med 2013; 19: 315-20. 10.1007/s11655-013-1437-323546635
Open DOI Search in Google Scholar Back to article
Bai N, He K, Zhou Z, Tsai ML, Zhang L, Quan Z, et al. Ent-kaurane diterpenoids from Rabdosia rubescens and their cytotoxic effects on human cancer cell lines. Planta Med 2010; 76: 140-5. 10.1055/s-0029-118600219653147
Open DOI Search in Google Scholar Back to article
Xu B, Shen W, Liu X, Zhang T, Ren J, Fan Y, et al. Oridonin inhibits BxPC-3 cell growth through cell apoptosis. Acta Biochim Biophys Sin (Shanghai) 2015; 47: 164-73. 10.1093/abbs/gmu13425651847
Open DOI Search in Google Scholar Back to article
Qi X, Zhang D, Xu X, Feng F, Ren G, Chu Q, et al. Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line. Int J Nanomedicine 2012; 7: 1793-804. 10.2147/IJN.S2948322619528
Open DOI Search in Google Scholar Back to article
Bu HQ, Liu DL, Wei WT, Chen L, Huang H, Li Y, et al. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Oncol Rep 2014; 31: 975-82. 10.3892/or.2013.288824297112
Open DOI Search in Google Scholar Back to article
Bu HQ, Luo J, Chen H, Zhang JH, Li HH, Guo HC, et al. Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway. Int J Oncol 2012; 41: 949-58. 10.3892/ijo.2012.151922710877
Open DOI Search in Google Scholar Back to article
Ikezoe T, Yang Y, Bandobashi K, Saito T, Takemoto S, Machida H, et al. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways. Mol Cancer Ther 2005; 4: 578-86. 10.1158/1535-7163.MCT-04-027715827331
Open DOI Search in Google Scholar Back to article
Liu JJ, Huang RW, Lin DJ, Peng J, Zhang M, Pan X, et al. Ponicidin, an entkaurane diterpenoid derived from a constituent of the herbal supplement PC-SPES, Rabdosia rubescens, induces apoptosis by activation of caspase-3 and mitochondrial events in lung cancer cells in vitro. Cancer Invest 2006; 24: 136-48. 10.1080/07357900500524371
Open DOI Search in Google Scholar Back to article
Liu JJ, Zhang Y, Guang WB, Yang HZ, Lin DJ, Xiao RZ. Ponicidin inhibits monocytic leukemia cell growth by induction of apoptosis. Int J Mol Sci 2008; 9: 2265-77. 10.3390/ijms911226519330074
Open DOI Search in Google Scholar Back to article
Zhang JF, Liu PQ, Chen GH, Lu MQ, Cai CJ, Yang Y, et al. Ponicidin inhibits cell growth on hepatocellular carcinoma cells by induction of apoptosis. Dig Liver Dis 2007; 39: 160-6. 10.1016/j.dld.2006.09.01117049940
Open DOI Search in Google Scholar Back to article
Liu YF, Lu YM, Qu GQ, Liu Y, Chen WX, Liao XH, et al. Ponicidin induces apoptosis via JAK2 and STAT3 signaling pathways in gastric carcinoma. Int J Mol Sci 2015; 16: 1576-89. 10.3390/ijms1601157625588213
Open DOI Search in Google Scholar Back to article
Murayama C, Nagao Y, Sano S, Ochiai M, Fuji K, Fujita E, et al. Effect of oridonin, a Rabdosia diterpenoid, on radiosensitization with misonidazole. Experientia 1987; 43: 1221-3.10.1007/BF019455333691743
Open DOI Search in Google Scholar Back to article
Zhou GB, Kang H, Wang L, Gao L, Liu P, Xie J, et al. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. Blood 2007; 109: 3441-50. 10.1182/blood-2006-06-032250
Open DOI Search in Google Scholar Back to article
Denekamp J, Waites T, Fowler JF. Predicting realistic RBE values for clinically relevant radiotherapy schedules. Int J Radiat Biol 1997; 71: 681-94.924618310.1080/095530097143699
Open DOI Search in Google Scholar Back to article
Steel GG, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 1979; 5: 85-91.10.1016/0360-3016(79)90044-0422420
Open DOI Search in Google Scholar Back to article
Morgan MA, Lawrence TS. Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways. Clin Cancer Res 2015; 21: 2898-904. 10.1158/1078-0432.CCR-13-322926133775
Open DOI Search in Google Scholar Back to article
Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL, Wu JM. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 2005; 337: 224-31. 10.1016/j.bbrc.2005.09.04016176802
Open DOI Search in Google Scholar Back to article
Roos WP, Kaina B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 2013; 332: 237-48. 10.1016/j.canlet.2012.01.00722261329
Open DOI Search in Google Scholar Back to article
MacPhail SH, Banath JP, Yu TY, Chu EH, Lambur H, Olive PL. Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. Int J Radiat Biol 2003; 79: 351-8.1294324310.1080/0955300032000093128
Open DOI Search in Google Scholar Back to article
Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 2002; 158: 486-92.1223681610.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2
Open DOI Search in Google Scholar Back to article
Zhang T, Tan Y, Zhao R, Liu Z. DNA damage induced by oridonin involves cell cycle arrest at G2/M phase in human MCF-7 cells. Contemp Oncol (Pozn) 2013; 17: 38-44. 10.5114/wo.2013.3377223788960
Open DOI Search in Google Scholar Back to article
Li YH, Wang X, Pan Y, Lee DH, Chowdhury D, Kimmelman AC. Inhibition of non-homologous end joining repair impairs pancreatic cancer growth and enhances radiation response. PLoS One 2012; 7: e39588. 10.1371/journal.pone.003958822724027
Open DOI Search in Google Scholar Back to article
Wang SQ, Wang C, Chang LM, Zhou KR, Wang JW, Ke Y, et al. Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathway. Oncotarget 2016; 7: 72990-3002. 10.18632/oncotarget.1216627659528
Open DOI Search in Google Scholar Back to article
Cao S, Xia M, Mao Y, Zhang Q, Donkor PO, Qiu F, et al. Combined oridonin with cetuximab treatment shows synergistic anticancer effects on laryngeal squamous cell carcinoma: involvement of inhibition of EGFR and activation of reactive oxygen species-mediated JNK pathway. Int J Oncol 2016; 49: 2075-87. 10.3892/ijo.2016.369627667173
Open DOI Search in Google Scholar Back to article